Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.
(NASDAQ:
RODM), today announced that Michael G. King, Jr., has rejoined the
firm in the position of Managing Director and Senior Biotechnology Analyst,
bringing his extensive sell-side experience as a biotechnology industry
analyst to Rodman.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
